Skip to content

Clinical trials

Terminated Phase 2 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2 Status: Terminated Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20072
20091
20154
20161
20181
20194
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arrowhead Pharmaceuticals5
Assembly Biosciences3
Bukwang Pharmaceutical3
F-star Therapeutics, Inc.3
Bausch Health Americas, Inc.1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Dynavax Technologies Corporation1
GlaxoSmithKline1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Noorik Biopharmaceuticals AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B20
Hepatitis B, Chronic8
Ascites1
Diphtheria1
Esophageal and Gastric Varices1
Fibrosis1
Haemophilus Infections1
Hepatitis1
Hepatitis C1
Hepatitis D1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.